Sue Duval, PhD

Associate Professor of Medicine, Cardiovascular Division

Sue Duval

Contact Info

Fax 612-626-4411

Office Address:
Cardiovascular Division
Variety Club Research Center
401 East River Parkway
2nd Floor
Minneapolis, Minnesota 55455

Mailing Address:
UMN – Cardiovascular Division
420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Administrative Assistant Name

Administrative Phone

Administrative Email

Administrative Fax Number

Associate Professor of Medicine, Cardiovascular Division

Division of Biostatistics

Biostatistics, University of Colorado Health Sciences Center, Denver, CO

Statistical Science, Flinders University of South Australia, Bedford Park, Australia


"Methodology is the core of excellence in cardiovascular health investigation."

Professor Duval received her BSc (Honors) in Statistical Science from Flinders University of South Australia in 1993 and her PhD in Biostatistics from the University of Colorado Health Sciences Center in 1999. She has served on the faculty of the Division of Epidemiology and Community Health (University of Minnesota) and joined the Lillehei Clinical Research Unit of the Cardiovascular Division in 2011. Her career has been dedicated to the application of methodological approaches to cardiovascular clinical research.

Prof. Duval has served as a faculty statistician in the AHRQ-funded "Evidence-based Practice Center (EPC)" at the University of Minnesota. She has achieved international recognition for the development of the "Trim and Fill" algorithm to address advanced issues in publication bias. Her paper on this topic in Biometrics 2000 has been cited over 3500 times.

She has been recognized as a Fellow of the American Heart Association and serves on the editorial board of the journal "Research Synthesis Methods", the official journal of the Society for Research Synthesis Methodology (SRSM). She is also a Statistical Editor for Circulation, and Vascular Medicine.

Awards & Recognition

  • University of Minnesota Medical School “Wall of Scholarship” Award* (2014)
  • Fellow of the American Heart Association, Peripheral Vascular Disease Council (2012)
  • Invited inaugural member, Society for Research Synthesis Methodology (2006)
  • The Strother G. Walker Award for outstanding performance in the biometrics PhD program, University of Colorado Health Sciences Center (1998)

*Awarded to faculty with first or last author credits on a publication that has been cited at least 1,000 times as indicated by two of three major citation indices (Google Scholar, Scopus, Web of Science).


Research Summary/Interests

  • Evaluation of the efficacy, harm and cost-effectiveness of cardiovascular disease behavioral, pharmacologic and device-based therapeutic interventions, spanning coronary artery and peripheral artery disease (PAD) syndromes, heart failure, and other cardiovascular diseases
  • Epidemiology of cardiovascular diseases
  • Analysis of administrative databases and registries
  • Meta-analytic methods applied to cardiovascular clinical trials and observational studies


  1. Cogswell R, Duval S, John R. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability. Int J Cardiol. 2018 May 9.[Epub ahead of print]
  2. Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP. External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarctionAtherosclerosis. 2018 May;272:80-86. Epub 2018 Mar 16.
  3. Duprez DA, Florea N, Duval S, Koukol C, Cohn JN. Effect of nebivolol or atenolol vs. placebo on cardiovascular health in subjects with borderline blood pressure: the EVIDENCE study. J Hum Hypertens. 2017 Dec;32(1):20-25. Epub 2017 Nov 28.
  4. Van't Hof JR, Duval S, Walts A, Kopecky SL, Luepker RV, Hirsch AT. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study. J Am Heart Assoc. 2017 Oct 3;6(10). pii: e006328.
  5. Kolla BC, Roy SS, Duval S, Weisdorf D, Valeti U, Blaes A. Cardiac Imaging Methods for Chemotherapy-related Cardiotoxicity Screening and Related Radiation Exposure: Current Practice and Trends. Anticancer Res. 2017 May;37(5):2445-2449.
  6. Cohn JN, Duprez DA, Hoke L, Florea N, Duval SOffice Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment. Hypertension. 2017 May;69(5):e14-e20. Epub 2017 Mar 27. Review. No abstract available.
  7. Prins KW, Duval S, Markowitz J, Pritzker M, Thenappan T. Chronic use of PAH-specific therapy in World Health Organization Group III Pulmonary Hypertension: a systematic review and meta-analysis. Pulm Circ. 2017 Mar 24;7(1):145-155.
  8. Kwon Y, Koene RJ, Kwon O, Kealhofer JV, Adabag S, Duval SEffect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2017 Feb;10(2):e004609. Review.
  9. Sporer K, Jacobs M, Derevin L, Duval S, Pointer J. Continuous Quality Improvement Efforts Increase Survival with Favorable Neurologic Outcome after Out-of-hospital Cardiac ArrestPrehosp Emerg Care. 2017 Jan-Feb;21(1):1-6. Epub 2016 Sep 14.
  10. Anand V, Roy SS, Archer SL, Weir EK, Garg SK, Duval S, Thenappan T. Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012. JAMA Cardiol. 2016 Dec 1;1(9):1021-1029.